CClinicalTrials.gg
Sign In
CompletedNCT07765394Updated Aug 14, 2026

A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health

An interventional study of Hello Burn Activate in Metabolic Health, Weight Management and Body Confidence, sponsored by Love Wellness. Completed at 1 site in United States. Open to participants aged 25 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Love Wellness · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
25 Years to 45 Years
Sex
All
01

Study summary

This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence.

All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.

02

Conditions studied

  • Metabolic Health
  • Weight Management
  • Body Confidence
  • Gut Health
03

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be female.
  • Be aged 25-45.
  • Currently experiencing issues regarding healthy weight management.
  • Currently experiencing issues regarding body confidence.
  • Currently experiencing difficulty maintaining a weight management routine.
  • Generally healthy - does not live with any uncontrolled chronic disease.
  • Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period.
  • Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
  • Resides in the United States.

Exclusion criteria

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
  • Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro.
  • Anyone taking a prescription anticoagulant ('blood thinner') medication.
  • Anyone taking a prescription antibiotic.
  • Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone participating in another research study within the next 12 weeks.
  • Anyone unwilling to follow the study protocol.
  • Anyone with any allergies or sensitivities to any of the study product ingredients.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Hello Burn Activate

    Dietary Supplement: Hello Burn Activate

Interventions

  • Dietary supplementHello Burn Activate

    All enrolled participants take one capsule of Hello Burn Activate (containing heat-treated Bifidobacterium animalis lactis BPL1, inulin, vegetable capsule \[hypromellose, water\], and medium chain triglycerides) once daily in the morning with the first meal of the day for 12 weeks.

05

What researchers measure

Primary outcomes

  1. Change in Perceived Metabolic Health

    Self-reported assessment of overall metabolic health via self-reported questionnaire

    Time frame: Baseline, Week 4, Week 8, and Week 12

Secondary outcomes

  1. Change in Body Confidence

    Self-reported assessment of body confidence via self-reported questionnaire

    Time frame: Baseline, Week 4, Week 8, and Week 12

  2. Change in Overall Well-Being

    Self-reported assessment of overall well-being via self-reported questionnaire

    Time frame: Baseline, Week 4, Week 8, and Week 12

  3. Change in Overall Health

    Self-reported assessment of overall health via self-reported questionnaire

    Time frame: Baseline, Week 4, Week 8, and Week 12

06

Study locations

1 site
  • Citruslabs
    Las Vegas, Nevada 89101, United States
07

Registry details

Key details

Study ID
NCT07765394
Lead sponsor
Love Wellness
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Apr 7, 2025
Primary completion
Jul 28, 2025
Completion
Jul 28, 2025
Last update
Aug 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Love Wellness

Start the discussion